Cheng Cheng Zhang
- Immunology top 2%
- Immune Cell Function and Interaction 26
- Phagocytosis and Immune Regulation 7
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 5
- Hematology top 2%
- Acute Myeloid Leukemia Research 10
- Hematopoietic Stem Cell Transplantation 7
- Oncology top 5%
- CAR-T cell therapy research 7
- Cancer Research top 5%
- Genetics top 5%
-
- Lipid metabolism and disorders 5
- Co-authors
- Wen JiangBetty Y.S. KimYang‐Xin FuIrving L. WeissmanMingye FengMi DengHarvey F. LodishQianming Wang
- Cited by
- ImmunologyHematologyOncology
- Journals
- Nature (2 papers)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Cheng Cheng Zhang
60 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Immunology 1.4k
- Hematology 407
- Oncology 623
- Cancer Research 328
- Genetics 203
Countries citing papers authored by Cheng Cheng Zhang
This map shows the geographic impact of Cheng Cheng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Cheng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Cheng Zhang more than expected).
Fields of papers citing papers by Cheng Cheng Zhang
This network shows the impact of papers produced by Cheng Cheng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Cheng Zhang. The network helps show where Cheng Cheng Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng Cheng Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 51 | |
| 8 | 2022 | 16 | |
| 9 | 2021 | 38 | |
| 10 | Phagocytosis checkpoints as new targets for cancer immunotherapybreakdown → | 2019 | 689 |
| 11 | 2018 | 7 | |
| 12 | 2018 | 30 | |
| 13 | 2017 | 19 | |
| 14 | 2015 | 241 | |
| 15 | 2015 | 49 | |
| 16 | 2015 | 15 | |
| 17 | 2015 | 6 | |
| 18 | 2013 | 30 | |
| 19 | 2011 | 69 | |
| 20 | 2011 | 8 |
About Cheng Cheng Zhang
Cheng Cheng Zhang is a scholar working on Hematology, Immunology and Genetics, having authored 62 papers that have together received 3.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (26 papers), Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (7 papers), CAR-T cell therapy research (7 papers), Phagocytosis and Immune Regulation (7 papers), Immunotherapy and Immune Responses (6 papers), Lipid metabolism and disorders (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Immunology (1.4k citations), Hematology (407 citations) and Oncology (623 citations). Cheng Cheng Zhang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Wen Jiang, Betty Y.S. Kim, Yang‐Xin Fu, Irving L. Weissman, Mingye Feng, Mi Deng, Harvey F. Lodish, Qianming Wang, Junke Zheng and Zhigang Lu. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.